Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 22, 2026
Reporting period
Not applicable
Filed with the SEC
May 26, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001071739-26-000123
Filed / recorded
May 26, 2026, 8:59 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
CENTENE CORP
Issuer CIK
1071739
Ticker
CNC
Reporting person
Michael A Carson
Relationship
Officer
Officer title
Group President, Medicare&Spec
Security
Phantom Stock
Table
Derivative (Table II)
Transaction date
May 22, 2026
Transaction code
A
Shares / units
47.935
Price per share
$57.77
Acquired / disposed
Acquired (A)
Shares owned after
604.004
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
The phantom stock was acquired by Mr. Carson through regularly scheduled payroll contributions to the Company's deferred compensation plan.
The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Carson's termination with the Company or on such other date Mr. Carson may elect.